Latest Breaking News On - Becky taub - Page 1 : comparemela.com

Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon

Good news could be in store for all three of these drugmakers.

United statesEli lillyBecky taubEuropean medicine agencyVertex pharmaceuticalsNovo nordiskRegeneron pharmaceuticalsCommittee for medicinal products human useEuropean unionDrug administrationMadrigal pharmaceuticalsMadrigal pharmaceuticalsMedical officer becky taubMarketing authorization applicationMedicinal productsHuman use

Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine

Resmetirom is the first investigational medicine for NASH to achieve fibrosis improvement and NASH resolution primary endpoints in a Phase 3 trial.

United statesSan antonioBecky taubStephen harrisonTina venturaPinnacle clinical researchExchange commissionSummit clinical researchMadrigal pharmaceuticals incOxford universityMadrigal pharmaceuticalsResearch development of madrigalNew england journalBreakthrough therapyPriority reviewPrescription drug user fee act

Madrigal Pharma (MDGL) Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom

Madrigal Pharma (MDGL) Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesStephen harrisonBecky taubResearch development of madrigalSummit clinical researchPinnacle clinical researchMadrigal pharmaceuticals incOxford universityMadrigal pharmaceuticalsNew england journalBreakthrough therapyPriority reviewPrescription drug user fee actVisiting professorPrincipal investigator

Resmetirom Significantly Reduces LDL-C, Restore Thyroid Hormones in NASH with Fibrosis

New analyses from the phase 3 MAESTRO-NASH support the oral daily drug's benefit for cardiovascular and hormonal outcomes over 1 year.

United statesStephena harrisonNaim alkhouriBecky taubPinnacle clinical researchMadrigal pharmaceuticalsDrug administrationFatty liver program at arizona healthMadrigal pharmaceuticals announcesLiver meetingAmerican associationLiver diseasesNew drug acceptanceTransplant hepatologyFatty liver programArizona liver health

Madrigal Pharma (MDGL) Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis

Madrigal Pharma (MDGL) Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Becky taubResearch development of madrigalDrug administrationRegistration program for the treatmentMadrigal pharmaceuticals incMadrigal pharmaceuticalsNew drug applicationPriority reviewPrescription drug user fee actChief executive officerChief medical officerResmetirom phase